Abstract:BACKGROUND: CD11clowCD45RBhigh regulatory dendritic cells (DCregs) have potential significance in participating the immune negative regulatory mechanism and clinical treatment. But it is still little about the induction and identification of human bone marrow-derived regulatory dendritic cells. OBJECTIVE: To induce the human bone marrow-derived CD11clowCD45RBhigh regulatory dendritic cells and identify them from the aspects of cell morphology, immunological phenotype, the ability of phagocytosis and stimulating T lymphocytes proliferation in vitro. METHODS: Mononuclear cells isolated from human bone marrow cells were induced and cultured with different cytokines in vitro. The cells were divided into three groups: (1)Regulatory dendritic cells group: regulatory dendritic cells were cultured for 7 days in RPMI 1640 culture medium containing granulocyte-macrophage colony-stimulating factor, interleukin-10 and transforming growth factor-β1, then stimulated with lipopolysaccharide for 24 hours. (2)Immature regulatory dendritic cells group: the immature regulatory dendritic cells were cultured for 8 days in RPMI 1640 culture medium containing granulocyte-macrophage colony-stimulating factor and interleukin-4. (3)Mature regulatory dendritic cells group: mature regulatory dendritic cells were cultured for 7 days in RPMI 1640 culture medium containing granulocyte-macrophage colony-stimulating factor and interleukin-4, and then stimulated with lipopolysaccharide for 24 hours to make them mature. The morphological phenotypes were observed under light and scanning microscope, the immunological phenotypes and ability of phagocytes were detected with flow cytometry, and the proliferative capacity of T cells stimulated by different subset of regulatory dendritic cells were examined by the Cell Count Kit-8. RESULTS AND CONCLUSION: Mononuclear cells separated from human bone marrow cells differentiated into a new CD11clowCD45RBhigh subset of regulatory dendritic cells after cultured in the culture medium of RPMI 1640 containing granulocyte-macrophage colony-stimulating factor and interleukin-10 and transforming growth factor-β1 for 8 days, which has the typical morphology and immunological phenotype, and their immunological phenotype and immunological function had the characteristics of immature regulatory dendritic cells. The results showed that our method to culture the regulatory dendritic cells was feasible. The CD11clowCD45RBhigh regulatory dendritic cell is a new subset of dendritic cell, which has the powerful of phagocytosis function and weak ability to stimulate the proliferation of T lymphocytes. Here we establish an experimental basis for the researched on regulatory dendritic cells in immune tolerance.

Generation of Regulatory Dendritic Cells after Treatment with Paeoniflorin.

Emodin Inhibits The Differentiation And Maturation Of Dendritic Cells And Increases The Production Of Regulatory T Cells

Regulatory dendritic cells program generation of interleukin-4–producing alternative memory CD4 T cells with suppressive activity

Transcription factor E2F1 suppresses dendritic cell maturation.

Paeoniflorin regulates the function of human peripheral blood mononuclear cells stimulated by rhIL-1β by up-regulating Treg expression

Pathway Analysis of Global Gene Expression Change in Dendritic Cells Induced by the Polysaccharide from the Roots of Actinidia Eriantha

Peucedanum Praeruptorum Dunn Polysaccharides Regulate Macrophage Inflammatory Response Through TLR2/TLR4-mediated MAPK and NF-κB Pathways.

Generation and Characterization of Regulatory Dendritic Cells Derived from Murine Induced Pluripotent Stem Cells

Induction and identification of CD11clowCD45RBhigh regulatory dendritic cells

[Effects of Vascular Endothelial Growth Factor on Differentiation and Function of Dendritic Cells Generated from CD34+ Hematopoietic Progenitor Cells in Vitro].

Phenotypic and functional characteristics of dendritic cells derived from human peripheral blood monocytes

Human anti-pig NK cell and CD8+ T-cell responses in the presence of regulatory dendritic cells

Paeoniflorin ameliorates chronic colitis via the DR3 signaling pathway in group 3 innate lymphoid cells

Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells

Paeoniflorin exerts antidepressant-like effects through enhancing neuronal FGF-2 by microglial inactivation

Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation

The effects and mechanism of paeoniflorin in promoting osteogenic differentiation of MC3T3-E1

Overexpression of Programmed Death Ligand 1 in Dendritic Cells Inhibits Allogeneic Lymphocyte Activation in Mice

Paeoniflorin prevents aberrant proliferation and differentiation of intestinal stem cells by controlling C1q release from macrophages in chronic colitis

Paeoniflorin ameliorates murine lupus nephritis by increasing CD4+Foxp3+ Treg cells via enhancing mTNFα-TNFR2 pathway

Echinacea Pupurea Extracts Promote Murine Dendritic Cell Maturation by Activation of JNK, P38 MAPK and NF-κB Pathways.